Appili Therapeutics Inc (APLI) - Total Liabilities

Latest as of December 2025: CA$16.93 Million CAD ≈ $12.25 Million USD

Based on the latest financial reports, Appili Therapeutics Inc (APLI) has total liabilities worth CA$16.93 Million CAD (≈ $12.25 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore APLI cash flow conversion to assess how effectively this company generates cash.

Appili Therapeutics Inc - Total Liabilities Trend (2017–2025)

This chart illustrates how Appili Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Check Appili Therapeutics Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Appili Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Appili Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Camellia Plc LSE:CAM	UK	GBX128.80 Million
OurLiving AB ST:OURLIV	Sweden	Skr8.99 Million
Mobeus Income And Growth Vct Plc LSE:MIX	UK	GBX880.32K
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares NASDAQ:CUPR	USA	$6.20 Million
Helios Underwriting PLC LSE:HUW	UK	GBX69.89 Million
Alpha Star Acquisition Corp NASDAQ:ALSA	USA	$4.46 Million
Fintech Chain Ltd AU:FTC	Australia	AU$54.97 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Appili Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Appili Therapeutics Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.03	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.03	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	30.90	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Appili Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Appili Therapeutics Inc (2017–2025)

The table below shows the annual total liabilities of Appili Therapeutics Inc from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	CA$16.43 Million ≈ $11.89 Million	+32.34%
2024-03-31	CA$12.42 Million ≈ $8.98 Million	+17.91%
2023-03-31	CA$10.53 Million ≈ $7.62 Million	-8.85%
2022-03-31	CA$11.55 Million ≈ $8.36 Million	+107.62%
2021-03-31	CA$5.56 Million ≈ $4.02 Million	+138.96%
2020-03-31	CA$2.33 Million ≈ $1.68 Million	-3.59%
2019-03-31	CA$2.42 Million ≈ $1.75 Million	+3.95%
2018-03-31	CA$2.32 Million ≈ $1.68 Million	+94.78%
2017-03-31	CA$1.19 Million ≈ $862.92K	--

About Appili Therapeutics Inc

TO:APLI Canada Biotechnology

Market Cap

$1.86 Million

CA$2.57 Million CAD

Market Cap Rank

#29757 Global

#1511 in Canada

Share Price

CA$0.02

Change (1 day)

+33.33%

52-Week Range

CA$0.01 - CA$0.04

All Time High

CA$1.87